This article is a correction to:
A Novel Chinese Herbal and Corresponding Chemical Formula for Cancer Treatment by Targeting Tumor Maintenance, Progression, and Metastasis
Ying-Chyi Song
Der-Yen Lee1
Pei-Yen Yeh- 1Graduate Institute of Integrated Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan
- 2TCM Division, Jin-Mi Company, Taipei, Taiwan
A Corrigendum on
A novel Chinese herbal and corresponding chemical formula for cancer treatment by targeting tumor maintenance, progression, and metastasis
by Song Y-C, Lee D-Y and Yeh P-Y (2022). Front. Pharmacol. 13:907826. doi: 10.3389/fphar.2022.907826
In the published article, there was an error. The labeling of the pan18 cells in the source is incorrect.
A correction has been made to Materials and Methods, Animal Study, paragraph one. This sentence previously stated:
“To establish the syngeneic mouse model of pancreatic tumors, Pan18 cells (GFP-LUC-tagged) derived from pancreatic tumors in EKP (elastase-CreER; LSL-KrasG12D; p53+/−) mice, kindly gifted from Dr. Yuh-Pyng Sher (China Medical University, Taichung, Taiwan), were used.”
The corrected sentence appears below:
“To establish the syngeneic mouse model of pancreatic tumors, Pan18 cells (GFP-LUC-tagged) derived from pancreatic tumors in EKP (elastase-CreER; LSL-KrasG12D; p53+/−) mice, kindly gifted from Dr. Chia-Ning Shen (Academia Sinica, Taipei, Taiwan), were used.”
In the published article, there was another error as Dr. CN Shen was erroneously omitted from the Acknowledgments.
A correction has been made to the Acknowledgments. The statement previously stated:
“We thank Dr. YS Lu (Department of Oncology, National Taiwan University Hospital) for helping with the cell growth and protein expression assays.”
The corrected statement appears below:
“We thank Dr. YS Lu (Department of Oncology, National Taiwan University Hospital) for helping with the cell growth and protein expression assays. We thank Dr. CN Shen (Academia Sinica, Taipei, Taiwan) for kindly providing the Pan18 cell line.”
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: cancer, botanical drug, Huang-Lian (Coptis chinensis Franch.), Huang-Qin (Scutellaria baicalensis Georgi), Bai-Wei (Vincetoxicum atratum (Bunge)
Citation: Song Y-C, Lee D-Y and Yeh P-Y (2023) Corrigendum: A novel Chinese herbal and corresponding chemical formula for cancer treatment by targeting tumor maintenance, progression, and metastasis. Front. Pharmacol. 14:1312683. doi: 10.3389/fphar.2023.1312683
Received: 10 October 2023; Accepted: 31 October 2023;
Published: 24 November 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Song, Lee and Yeh. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ying-Chyi Song, c29uZ3lpbmdjaHlpQGdtYWlsLmNvbQ==; Pei-Yen Yeh, eWVocGVpeUB5YWhvby5jb20udHc=